The additive for high-purity copper electrolytic refining of the present invention is an additive which is added to a copper electrolyte in electrolytic refining for high-purity copper and is formed of a non-ionic surfactant that includes a hydrophobic group containing an aromatic ring and a hydrophilic group containing a polyoxyalkylene group.

A method of treatment of infection in a subject comprising administering to the subject a copolymer comprising an acrolein derived segment or a polyacrolein oligomer segment and a polyalkylene glycol oligomer segment, the copolymer having a molecular weight of no more than 1500 Daltons.

Disclosed herein are glycidol-based polymers, nanoparticles, and methods related thereto useful for a variety of applications, including, but not limited to, drug delivery. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Polyoxymethylene, where a ratio of a low molecular weight component having a molecular weight of 10,000 or less in a molecular weight distribution is 7.0% or less of the total, and the molecular weight distribution is obtained by measurement by gel permeation chromatography (GPC) using polymethyl methacrylate (PMMA) as a standard substance.

Disclosed herein are glycidol-based polymers, nanoparticles, and methods related thereto useful for a variety of applications, including, but not limited to, drug delivery. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Provided is a compound with which a lubricant having excellent adhesion to a magnetic disk, particularly to a protective layer can be provided. A perfluoropolyether compound in accordance with one aspect of this invention has a structure in which two perfluoropolyethers are bonded to each other through an aliphatic ether, the aliphatic ether including a carbon atom to which a primary alcohol is bonded.

A random copolymer compound of (A) a polyphenylene ether resin having phenolic hydroxy groups at both ends, (B) an aliphatic polymer having alcoholic hydroxy groups at both ends, and (C) an acid dichloride compound that is a binder is disclosed, wherein the number of mol a of the (A) polyphenylene ether resin, the number of mol b of the (B) aliphatic polymer, and the number of mol c of the (C) acid dichloride compound that is a binder satisfies the relationship (a+b)>c.

A polyarylether-based polymer with side chain in methoxypolyethylene glycols structure, a solid polymer electrolyte and preparation methods therefore are disclosed. The main chain of the polymer has a polymer structure containing a polyarylether group, the side chain has a methoxypolyethylene glycols structure, and the structural formula of the polyarylether-based polymer is as follows: ##STR00001##
and the preparation method for the polyarylether-based polymer with side chain in methoxypolyethylene glycols structure comprises: step (1): preparing a polymer containing a polyarylether group; and step (2): dissolving the polymer containing a polyarylether group and methoxypolyethylene glycols in a solvent, then adding a catalyst, dripping a co-catalyst after the catalyst is dissolved, and conducting reaction while stirring to obtain the polyarylether-based polymer with side chain in methoxypolyethylene glycols structure. The all-solid polymer electrolyte prepared by the present invention has favorable ionic conductivity and excellent heat resistance, high temperature resistance and mechanical strength.

To provide a hydrophilic polymer derivative having a novel linker technique which is able to from a hydrophilic polymer pro-drug of a drug containing an amino group or the like in order to overcome the restrictions of conventional hydrophilic polymer pro-drugs. A hydrophilic polymer derivative containing a hydrophilic polymer moiety and an acetal moiety, wherein the hydrophilic polymer derivative contains a structure represented by formula (1) or formula (2): ##STR00001##

The present invention relates to the use of at least one tetra functional non-ionic amphiphilic block copolymer as a vehicle for capped or uncapped mRNA for intracellular delivery for gene therapy.